1. Home
  2. BLIN vs SYBX Comparison

BLIN vs SYBX Comparison

Compare BLIN & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$0.80

Market Cap

12.1M

Sector

Technology

ML Signal

HOLD

Logo Synlogic Inc.

SYBX

Synlogic Inc.

HOLD

Current Price

$1.16

Market Cap

15.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLIN
SYBX
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
15.2M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
BLIN
SYBX
Price
$0.80
$1.16
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.62
N/A
AVG Volume (30 Days)
82.3K
78.8K
Earning Date
12-18-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,383,000.00
N/A
Revenue This Year
$19.02
N/A
Revenue Next Year
$23.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.16
N/A
52 Week Low
$0.90
$0.90
52 Week High
$2.80
$1.96

Technical Indicators

Market Signals
Indicator
BLIN
SYBX
Relative Strength Index (RSI) 26.56 42.29
Support Level $0.94 $1.15
Resistance Level $0.97 $1.22
Average True Range (ATR) 0.08 0.06
MACD -0.01 0.03
Stochastic Oscillator 26.38 62.50

Price Performance

Historical Comparison
BLIN
SYBX

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: